Finally, multiplexed inflammatory factor immunoassays revealed a dysfunctional immune phenotype in both IBD (stool) and PD (plasma) cohorts, where CCL22 correlated with both PD disease duration and ferritin load, as compared to NHC. Here, CCL22 is linked to inflammatory bowel disease.